{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:48:43Z","timestamp":1761238123686},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"American Lebanese Syrian Associated Charities (ALSAC)"},{"DOI":"10.13039\/100007737","name":"St. Jude Children's Research Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM086415","GM110034"],"award-info":[{"award-number":["GM086415","GM110034"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA21765"],"award-info":[{"award-number":["P30-CA21765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bcp.2014.08.025","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T16:35:22Z","timestamp":1409416522000},"page":"389-402","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Thiazide-like diuretic drug metolazone activates human pregnane X receptor to induce cytochrome 3A4 and multidrug-resistance protein 1"],"prefix":"10.1016","volume":"92","author":[{"given":"Monimoy","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taosheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2014.08.025_bib0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/pr.58.4.2","article-title":"Overview of nomenclature of nuclear receptors","volume":"58","author":"Germain","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2014.08.025_bib0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1210\/me.2005-0046","article-title":"The nuclear receptor superfamily: a Rosetta Stone for physiology","volume":"19","author":"Evans","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd753","article-title":"CAR and drug metabolism","volume":"1","author":"Willson","year":"2002","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.bcp.2014.08.025_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.taap.2013.05.014","article-title":"Piperine activates human pregnane X receptor to induce the expression of cytochrome P450 3A4 and multidrug resistance protein 1","volume":"272","author":"Wang","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0025","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1208\/s12248-009-9135-y","article-title":"Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines","volume":"11","author":"Chang","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.bcp.2014.08.025_bib0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.mam.2009.04.002","article-title":"Nuclear receptors CAR and PXR: molecular, functional, and biomedical aspects","volume":"30","author":"di Masi","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.bcp.2014.08.025_bib0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1517\/17425255.2.6.847","article-title":"Pregnane X receptor and natural products: beyond drug\u2013drug interactions","volume":"2","author":"Staudinger","year":"2006","journal-title":"Expert Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0040","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1126\/science.1060762","article-title":"The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity","volume":"292","author":"Watkins","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bcp.2014.08.025_bib0045","first-page":"150","article-title":"Structural insights into the promiscuity and function of the human pregnane X receptor","volume":"5","author":"Watkins","year":"2002","journal-title":"Curr Opin Drug Discovery Dev"},{"key":"10.1016\/j.bcp.2014.08.025_bib0050","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1021\/bi0268753","article-title":"2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin","volume":"42","author":"Watkins","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2014.08.025_bib0055","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-2836(03)00795-2","article-title":"Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor","volume":"331","author":"Watkins","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0060","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1210\/me.2006-0323","article-title":"Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition","volume":"21","author":"Xue","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0065","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.3390\/molecules18077389","article-title":"Modulation of xenobiotic receptors by steroids","volume":"18","author":"Banerjee","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2014.08.025_bib0070","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/1078-0432.CCR-05-0252","article-title":"Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agents","volume":"11","author":"Mani","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2014.08.025_bib0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/mol.111.071787","article-title":"In vivo and in vitro characterization of a first-in-class novel azole analog that targets pregnane X receptor activation","volume":"80","author":"Venkatesh","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/dmd.30.1.96","article-title":"A pharmacophore for human pregnane X receptor ligands","volume":"30","author":"Ekins","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2014.08.025_bib0085","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cbpa.2008.07.001","article-title":"Nuclear receptor drug discovery","volume":"12","author":"Chen","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0090","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbadis.2011.01.014","article-title":"Nuclear receptor PXR, transcriptional circuits and metabolic relevance","volume":"1812","author":"Ihunnah","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2014.08.025_bib0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mce.2010.06.016","article-title":"Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR","volume":"334","author":"Krasowski","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0100","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bcp.2013.07.023","article-title":"Differential regulation of CYP3A4 promoter activity by a new class of natural product derivatives binding to pregnane X receptor","volume":"86","author":"Banerjee","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1359-6446(04)03061-2","article-title":"Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism","volume":"9","author":"Xie","year":"2004","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.bcp.2014.08.025_bib0110","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nbt.1581","article-title":"Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries","volume":"27","author":"Veith","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P-450 3A4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0120","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.bcp.2012.01.030","article-title":"Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters","volume":"83","author":"Chen","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1081\/DMR-100102338","article-title":"The human CYP3A subfamily: practical considerations","volume":"32","author":"Wrighton","year":"2000","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.bcp.2014.08.025_bib0130","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.289.13.1652","article-title":"Drug\u2013drug interactions among elderly patients hospitalized for drug toxicity","volume":"289","author":"Juurlink","year":"2003","journal-title":"JAMA\u2014J Am Med Assoc"},{"key":"10.1016\/j.bcp.2014.08.025_bib0135","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.4.5782.266","article-title":"Use of metolazone in the treatment of ascites due to liver disease","volume":"4","author":"Hillenbrand","year":"1971","journal-title":"Br Med J"},{"key":"10.1016\/j.bcp.2014.08.025_bib0140","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1124\/jpet.106.104901","article-title":"Beneficial effects of metolazone in a rat model of preeclampsia","volume":"318","author":"Pridjian","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2014.08.025_bib0145","first-page":"434","article-title":"The role of outpatient intravenous diuretic therapy in a transitional care program for patients with heart failure: a case series","volume":"4","author":"Lazkani","year":"2012","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.bcp.2014.08.025_bib0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1590-8658(01)80029-3","article-title":"Metolazone-induced cholestatic liver disease","volume":"33","author":"Gabrielli","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bcp.2014.08.025_bib0155","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.bmcl.2008.03.051","article-title":"Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct","volume":"18","author":"Temperini","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2014.08.025_bib0160","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.93.9.4001","article-title":"P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans","volume":"93","author":"Schuetz","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.08.025_bib0165","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccr.2014.02.009","article-title":"Pemetrexed and gemcitabine as combination therapy for the treatment of group3 medulloblastoma","volume":"25","author":"Morfouace","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2014.08.025_bib0170","doi-asserted-by":"crossref","first-page":"30650","DOI":"10.1074\/jbc.M806132200","article-title":"Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells","volume":"283","author":"Lin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.08.025_bib0175","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.bcp.2014.08.025_bib0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/BJ20130558","article-title":"Stability of the human pregnane X receptor is regulated by E3 ligase UBR5 and serine\/threonine kinase DYRK2","volume":"459","author":"Ong","year":"2014","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2014.08.025_bib0185","unstructured":"Chemical Computing Group Inc. Molecular operating environment (MOE) software. \u3008http:\/\/www.chemcomp\/com\u3009."},{"key":"10.1016\/j.bcp.2014.08.025_bib0190","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/me.2004-0346","article-title":"Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin","volume":"19","author":"Chrencik","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0195","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1073\/pnas.95.21.12208","article-title":"Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction","volume":"95","author":"Bertilsson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.08.025_bib0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/dmd.110.035808","article-title":"Identification and validation of novel human pregnane X receptor activators among prescribed drugs via ligand-based virtual screening","volume":"39","author":"Pan","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2014.08.025_bib0205","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/tx800102e","article-title":"Machine learning methods and docking for predicting human pregnane X receptor activation","volume":"21","author":"Khandelwal","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0210","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bcp.2013.04.002","article-title":"Agonism of human pregnane X receptor by rilpivirine and etravirine: comparison with first generation non-nucleoside reverse transcriptase inhibitors","volume":"85","author":"Sharma","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0215","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/0091270004269142","article-title":"Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital","volume":"44","author":"Hariparsad","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2014.08.025_bib0220","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/138920006776873535","article-title":"Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions","volume":"7","author":"Sinz","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.bcp.2014.08.025_bib0225","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00216-009-3310-y","article-title":"Evaluation of an hPXR reporter gene assay for the detection of aquatic emerging pollutants: screening of chemicals and application to water samples","volume":"396","author":"Creusot","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.bcp.2014.08.025_bib0230","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1124\/dmd.108.024695","article-title":"A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor","volume":"37","author":"Pondugula","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2014.08.025_bib0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00003088-200038060-00003","article-title":"Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans","volume":"38","author":"Fuhr","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bcp.2014.08.025_bib0240","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJM199803263381314","article-title":"Hepatic dysfunction associated with troglitazone","volume":"338","author":"Watkins","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2014.08.025_bib0245","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1073\/pnas.130155097","article-title":"St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor","volume":"97","author":"Moore","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.08.025_bib0250","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2165\/11317010-000000000-00000","article-title":"Interactions between herbal medicines and prescribed drugs: an updated systematic review","volume":"69","author":"Izzo","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2014.08.025_bib0255","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1124\/dmd.110.032128","article-title":"Protein phosphatase 2Cbetal regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells","volume":"38","author":"Pondugula","year":"2010","journal-title":"Drug Metab Dispos"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214004985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214004985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T01:23:45Z","timestamp":1538270625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214004985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0006295214004985"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.08.025","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiazide-like diuretic drug metolazone activates human pregnane X receptor to induce cytochrome 3A4 and multidrug-resistance protein 1","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}